Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice
- 31 January 2008
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 209 (1), 161-170
- https://doi.org/10.1016/j.expneurol.2007.09.018
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growthEuropean Journal Of Cancer, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: Potential signaling mechanismsJournal of Neuroscience Research, 2006
- Emerging biological roles for erythropoietin in the nervous systemNature Reviews Neuroscience, 2005
- Erythropoietin is neuroprotective in models of HIV sensory neuropathyNeuroscience Letters, 2004
- A novel endogenous erythropoietin mediated pathway prevents axonal degenerationAnnals of Neurology, 2004
- Erythropoietin, Glutamate, and NeuroprotectionNew England Journal of Medicine, 2004
- Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failure: a case reportClinical Autonomic Research, 2002
- Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse.Proceedings of the National Academy of Sciences, 1996
- Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failureClinical Autonomic Research, 1995